Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Lucas Antônio, Miranda Ferreira"'
Autor:
Eduardo Burgarelli Lages, Renata Salgado Fernandes, Marina Mol Sena Andrade, Nitchawat Paiyabhroma, Renata Barbosa de Oliveira, Christian Fernandes, Geovanni Dantas Cassali, Pierre Sicard, Sylvain Richard, André Luís Branco de Barros, Lucas Antônio Miranda Ferreira
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 144, Iss , Pp 112373- (2021)
Side effects often limit the use of doxorubicin (DOX) in cancer treatment. We have recently developed a nanostructured lipid carrier (NLC) formulation for synergistic chemotherapy, encapsulating DOX and the anticancer adjuvants docosahexaenoic acid (
Externí odkaz:
https://doaj.org/article/ab30badd949049e1a663721747a3b7e3
Autor:
Gabriel Silva Marques Borges, Pedro Henrique Dias Moura Prazeres, Ângelo Malachias de Souza, Maria Irene Yoshida, José Mario Carneiro Vilela, Aline Teixeira Maciel e Silva, Mariana Silva Oliveira, Dawidson Assis Gomes, Margareth Spangler Andrade, Elaine Maria de Souza-Fagundes, Lucas Antônio Miranda Ferreira
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 57 (2021)
Sclareol (SC) is arousing great interest due to its cytostatic and cytotoxic activities in several cancer cell lines. However, its hydrophobicity is a limiting factor for its in vivo administration. One way to solve this problem is through nanoencaps
Externí odkaz:
https://doaj.org/article/7f30d5648768413f8a269d098c0b0082
Autor:
Gabriel Silva Marques Borges, Eduardo Burgarelli Lages, Pierre Sicard, Lucas Antônio Miranda Ferreira, Sylvain Richard
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Cancer and cardiovascular diseases are the leading causes of death and morbidity worldwide. Strikingly, cardiovascular disorders are more common and more severe in cancer patients than in the general population, increasing incidence rates. In this co
Externí odkaz:
https://doaj.org/article/fae1ab95d8184888bb31c425126476c5
Publikováno v:
Nanomedicine. 18:579-582
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ff0f3f906eeedae2258a78c4acf63da
https://doi.org/10.2217/nnm-2023-0085
https://doi.org/10.2217/nnm-2023-0085
Autor:
Carolina Henriques Cavalcante, Renata Salgado Fernandes, Juliana de Oliveira Silva, Caroline Mari Ramos Oda, Elaine Amaral Leite, Geovanni Dantas Cassali, Ives Charlie-Silva, Bianca Helena Ventura Fernandes, Lucas Antônio Miranda Ferreira, Andre Luis Branco de Barros
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 134, Iss , Pp 111076- (2021)
Doxorubicin (DOX) is an anthracycline antibiotic widely used in the treatment of cancer, however, it is associated with the occurrence of adverse reactions that limits its clinical use. In this context, the encapsulation of DOX in micelles responsive
Externí odkaz:
https://doaj.org/article/e3a2a2364c124484ac4a99de92924bfe
Autor:
Sued Eustáquio Mendes Miranda, Janaína de Alcântara Lemos, Renata Salgado Fernandes, Juliana de Oliveira Silva, Flaviano M. Ottoni, Danyelle M. Townsend, Domenico Rubello, Ricardo José Alves, Geovanni Dantas Cassali, Lucas Antônio Miranda Ferreira, Andre Luis Branco de Barros
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 133, Iss , Pp 110936- (2021)
Lapachol (LAP) is a natural compound with various biological properties, including anticancer activity. However, its clinical application is limited due to the low aqueous solubility and potential adverse side effects. Nanoemulsions are drug delivery
Externí odkaz:
https://doaj.org/article/7872de298b554214bc2cc732bee34524
Autor:
Eduardo Burgarelli Lages, Renata Salgado Fernandes, Juliana de Oliveira Silva, Ângelo Malachias de Souza, Geovanni Dantas Cassali, André Luís Branco de Barros, Lucas Antônio Miranda Ferreira
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 132, Iss , Pp 110876- (2020)
Doxorubicin (DOX) is widely used in cancer treatment, however, its use is often limited due to its side effects. To avoid these shortcomings, the encapsulation of DOX into nanocarriers has been suggested. Herein, we proposed a novel nanostructured li
Externí odkaz:
https://doaj.org/article/0870edcf498748cb8c83fbd60abde9f6
Autor:
Letícia Márcia da Silva Tinoco, Flávia Lidiane Oliveira da Silva, Lucas Antônio Miranda Ferreira, Elaine Amaral Leite, Guilherme Carneiro
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 54, Iss 4 (2019)
All-trans retinoic acid (ATRA) has been studied for the treatment of cancer, including leukemia and breast cancer. This work aims to develop nanoemulsions (NE) loaded with a hydrophobic ion pair (HIP) of all-trans retinoic acid (ATRA) and a lipophili
Externí odkaz:
https://doaj.org/article/b2bafde2e8294f149dada03934d7f106
Autor:
Gabriel Silva Marques Borges, Pierre Sicard, Cristina de Mello Gomides Loures, Fernanda Gontijo Cristina Evangelista, Camila Campos Sales, Adriano de Paula Sabino, Christian Fernandes, Lucas Antônio Miranda Ferreira, Sylvain Richard
Publikováno v:
AAPS PharmSciTech. 24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d7d9d1b93a52c54e25a7c0c7da82b95
https://doi.org/10.1208/s12249-023-02531-w
https://doi.org/10.1208/s12249-023-02531-w
Autor:
Danielle Sóter do Nascimento Damasio, Patrícia Andrade Antunes, Eduardo Burgarelli Lages, Eliane de Morais-Teixeira, Kátia Duarte Vital, Valbert Nascimento Cardoso, Simone Odılia Antunes Fernandes, Marta Gontijo Aguiar, Lucas Antônio Miranda Ferreira
Publikováno v:
International journal of pharmaceutics. 631
The aim of this study was to develop, characterize and evaluate the in vivo oral efficacy of self-emulsifying drug delivery systems (SEDDS) containing fexinidazole (FEX) in the experimental treatment of visceral leishmaniasis (VL). The developed FEX-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bb15a68c85659edb1dcb1c9b1cf979d
https://pubmed.ncbi.nlm.nih.gov/36549405
https://pubmed.ncbi.nlm.nih.gov/36549405